11th International Conference on Cryptococcus and Cryptococcosis (ICCC)
第十一届隐球菌和隐球菌病国际会议(ICCC)
基本信息
- 批准号:10399173
- 负责人:
- 金额:$ 1.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-01 至 2023-01-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAdultAffectAfricaAfrica South of the SaharaAfricanAntifungal AgentsAntifungal TherapyArchivesAreaBasic ScienceBotswanaCOVID-19 pandemicCaringCentral Nervous System InfectionsCessation of lifeCharacteristicsClinicalClinical InvestigatorClinical SciencesClinical TrialsCollaborationsCommunicable DiseasesCommunitiesCountryCryptococcal MeningitisCryptococcosisCryptococcusCryptococcus neoformansDiseaseEtiologyFaceFailureFamilyFloorFosteringFundingFutureGenomeGoalsGrantHIVHIV antiretroviralImmune systemImmunityImmunocompetentImmunocompromised HostImmunosuppressionIncidenceIncomeInternationalInternational AspectsInvadedKnowledgeMedicalMeningitisMicrobiologyMinorityMolecularMorbidity - disease rateMycosesOpportunistic InfectionsOralParticipantPathogenesisPathogenicityPatientsPersonsPostdoctoral FellowPredispositionPrevention strategyProgram DevelopmentPropertyRequest for ProposalsResearchResearch PersonnelResourcesRetroviridae InfectionsRiskScientific Advances and AccomplishmentsScientistSexual ReproductionSignal TransductionSiteSouth AfricaStructureStudentsThe science of MycologyTimeTranslational ResearchTravelTwitterUgandaUnderrepresented MinorityUnited States National Institutes of HealthVirulenceWheelchairsWomanantiretroviral therapycareerclinical practicedigitalfungusgraduate studentinnovationmeetingsmortalityneglectnovelpandemic diseaseparitypathogenpost-COVID-19posterspreclinical developmentprogramsscreeningsocial mediasymposiumtherapy developmenttooltreatment strategyvaccine developmentweb siteworking group
项目摘要
ABSTRACT
This proposal requests partial support for the 11th International Conference on Cryptococcus and
Cryptococcosis (ICCC) to be held in Kampala, Uganda, January 10-14, 2022. Cryptococcosis accounts for
15% of AIDS-related deaths globally. Cryptococcal meningitis remains the most common neuroinfection
among all adults in Sub-Saharan Africa and continues to be a major threat to a growing number of non-HIV
immunocompromised persons.
The broad and long-term goal of this ICCC is to bring together the world's leading researchers in this
expanding field to foster cross-disciplinary discussions, research, and clinical collaborations to enhance our
understanding of the mechanisms of Cryptococcus pathogenicity and best management of cryptococcosis.
The specific aims of this meeting will be to convene leading experts whose expertise covers critical
areas within this field, as well as early career and junior investigators, students, and postdocs. We
anticipate hosting 300 participants. The program will be structured into 17 sessions covering the diverse
properties and characteristics of the pathogen as well as host susceptibility and immunity, emphasizing
what makes a normal host suddenly susceptible to this disease. Importantly, the conference will provide
ample coverage of current and novel antifungals – ranging from pre-clinical development programs through
ongoing/future clinical trials. Abstracts from junior investigators, graduate students, and postdoctoral fellows
will be included among those selected for oral presentation. The conference will host two poster sessions
which will permit all participants to actively contribute to these topics. Of the 17 session blocks, 12 blocks
will be concurrent sessions to allow for smaller working groups to meet and more students / trainees to
present their abstracts. The R13 resources will go towards supporting travel grant participation by graduate
students and specifically under-represented minority scholars from US and Africa who present abstracts.
We will seek parity with respect to women and minorities in the selection of speakers and organizing
committee, starting with 2 of the 3 ICCC co-chairs being a woman or a minority. We will target at least
~40% of plenary speakers to be women and ~10% under-represented minorities. Childcare will be provided.
The 11th ICCC is significant because focuses on an important infectious disease afflicting both
immunocompromised and immunocompetent people. This is the only such conference that brings together
basic scientists and clinical investigators who investigate cryptococcosis. This is the first time the
conference will be held in Africa with objectives: 1) to build new US-African translational research
collaborations; 2) to define the important clinical, translational, and basic science research agenda to forge
new avenues for novel prevention and treatment strategies.
抽象的
该提案请求对第十一届隐球菌国际会议给予部分支持
隐球菌病 (ICCC) 将于 2022 年 1 月 10 日至 14 日在乌干达坎帕拉举行。隐球菌病占
全球 15% 的艾滋病相关死亡病例仍然是最常见的神经感染。
在撒哈拉以南非洲地区的所有成年人中,这种疾病仍然是对越来越多的非艾滋病毒感染者的主要威胁
免疫功能低下的人。
ICCC 的广泛而长期的目标是汇集该领域世界领先的研究人员
扩大领域,促进跨学科讨论、研究和临床合作,以增强我们的能力
了解隐球菌致病机制和隐球菌病的最佳管理。
这次会议的具体目标是召集领先的专家,他们的专业知识涵盖关键领域
该领域的各个领域,以及早期职业和初级研究人员、学生和博士后。
预计将接待 300 名参与者,该计划将分为 17 个会议,涵盖不同的领域。
病原体的特性和特征以及宿主的易感性和免疫力,强调
重要的是,会议将提供什么使正常宿主突然容易感染这种疾病。
广泛涵盖当前和新型抗真菌药物——从临床前开发计划到
正在进行/未来的临床试验摘要来自初级研究人员、研究生和博士后研究员。
会议将举办两场墙报会议。
这将允许所有参与者积极为这些主题做出贡献,在 17 个会话块中,有 12 个块。
将同时举行会议,以便较小的工作组能够开会,并允许更多的学生/受训者
R13 资源将用于支持毕业生参与旅行补助金。
来自美国和非洲的学生,特别是代表性不足的少数族裔学者,他们提交了摘要。
我们将在选择演讲者和组织活动时寻求对妇女和少数族裔的平等对待
委员会,从 3 位 ICCC 联合主席中的 2 位开始,我们将至少瞄准女性或少数族裔。
约 40% 的全体发言者为女性,约 10% 的代表性不足的少数族裔将获得儿童保育服务。
第 11 届 ICCC 意义重大,因为重点关注了一种影响两国人民的重要传染病
这是唯一将免疫功能低下和免疫功能正常的人聚集在一起的会议。
基础科学家和临床研究人员对隐球菌病进行研究,这是第一次。
会议将在非洲举行,目标是:1)建立新的美非转化研究
合作;2)确定重要的临床、转化和基础科学研究议程
新的预防和治疗策略的新途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David R Boulware其他文献
Randomized trial of mechanotherapy for the treatment of stress urinary incontinence in women
机械疗法治疗女性压力性尿失禁的随机试验
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:2
- 作者:
Nissrine A. Nakib;Suzette Sutherland;Kevin Hallman;Marcus Mianulli;David R Boulware - 通讯作者:
David R Boulware
David R Boulware的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David R Boulware', 18)}}的其他基金
Encochleated Oral Amphotericin for HIV-related Cryptococcal Meningitis Trial: Phase 3 Trial
包埋口服两性霉素治疗 HIV 相关隐球菌性脑膜炎试验:3 期试验
- 批准号:
10619788 - 财政年份:2023
- 资助金额:
$ 1.7万 - 项目类别:
TB Meningitis: Evaluating CSF Immunology to Discover Hidden Disease and Potential Immunomodulatory Therapies
结核性脑膜炎:评估脑脊液免疫学以发现隐藏疾病和潜在的免疫调节疗法
- 批准号:
10675513 - 财政年份:2021
- 资助金额:
$ 1.7万 - 项目类别:
TB Meningitis: Evaluating CSF Immunology to Discover Hidden Disease and Potential Immunomodulatory Therapies
结核性脑膜炎:评估脑脊液免疫学以发现隐藏疾病和潜在的免疫调节疗法
- 批准号:
10459614 - 财政年份:2021
- 资助金额:
$ 1.7万 - 项目类别:
TB Meningitis: Evaluating CSF Immunology to Discover Hidden Disease and Potential Immunomodulatory Therapies
结核性脑膜炎:评估脑脊液免疫学以发现隐藏疾病和潜在的免疫调节疗法
- 批准号:
10335501 - 财政年份:2021
- 资助金额:
$ 1.7万 - 项目类别:
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial
包埋口服两性霉素治疗隐球菌性脑膜炎试验
- 批准号:
10163929 - 财政年份:2019
- 资助金额:
$ 1.7万 - 项目类别:
Encochleated Oral Amphotericin for Cryptococcal Meningitis Trial
包埋口服两性霉素治疗隐球菌性脑膜炎试验
- 批准号:
10364704 - 财政年份:2019
- 资助金额:
$ 1.7万 - 项目类别:
Phased Implementation of a Public Health Programme: Cryptococcal Screening and Treatment in South Africa
公共卫生计划的分阶段实施:南非的隐球菌筛查和治疗
- 批准号:
9232071 - 财政年份:2016
- 资助金额:
$ 1.7万 - 项目类别:
Cryptococcal Antigen Screening plus Sertraline (C-ASSERT)
隐球菌抗原筛查加舍曲林 (C-ASSERT)
- 批准号:
9925177 - 财政年份:2016
- 资助金额:
$ 1.7万 - 项目类别:
Cryptococcal Antigen Screening plus Sertraline (C-ASSERT)
隐球菌抗原筛查加舍曲林 (C-ASSERT)
- 批准号:
9914429 - 财政年份:2016
- 资助金额:
$ 1.7万 - 项目类别:
Cryptococcal Antigen Screening plus Sertraline (C-ASSERT)
隐球菌抗原筛查加舍曲林 (C-ASSERT)
- 批准号:
9271847 - 财政年份:2016
- 资助金额:
$ 1.7万 - 项目类别:
相似国自然基金
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
依恋相关情景模拟对成人依恋安全感的影响及机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
生活方式及遗传背景对成人不同生命阶段寿命及死亡的影响及机制的队列研究
- 批准号:
- 批准年份:2021
- 资助金额:56 万元
- 项目类别:面上项目
成人与儿童结核病发展的综合研究:细菌菌株和周围微生物组的影响
- 批准号:81961138012
- 批准年份:2019
- 资助金额:100 万元
- 项目类别:国际(地区)合作与交流项目
统计学习影响成人汉语二语学习的认知神经机制
- 批准号:31900778
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM) Research Core & MHD-CE
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
- 批准号:
10686545 - 财政年份:2023
- 资助金额:
$ 1.7万 - 项目类别:
Treatment Development for Smoking Cessation and Engagement in HIV/TB Care in South Africa
南非戒烟和参与艾滋病毒/结核病护理的治疗方法开发
- 批准号:
10706874 - 财政年份:2023
- 资助金额:
$ 1.7万 - 项目类别:
SUPPORT SERVICES FOR THE PREVENTION AND TREATMENT THROUGH A COMPREHENSIVE CARE CONTINUUM FOR HIV-AFFECTED ADOLESCENTS IN RESOURCE CONSTRAINED SETTINGS IMPLEMENTATION SCIENCE NETWORK
通过全面护理连续体为资源有限环境中受艾滋病毒影响的青少年提供预防和治疗支持服务 实施科学网络
- 批准号:
10917617 - 财政年份:2023
- 资助金额:
$ 1.7万 - 项目类别:
Omuyambi: Traditional healer support to improve HIV viral suppression in rural Uganda
Omuyambi:传统治疗师支持改善乌干达农村地区的艾滋病病毒抑制
- 批准号:
10619333 - 财政年份:2023
- 资助金额:
$ 1.7万 - 项目类别: